Hepion Pharmaceuticals, Inc.
HEPA· OTC
HEPAHepion Pharmaceuticals, Inc.
Filed Mar 12, 2026 · 10-K · 71 days after period end · 0001493152-26-009755
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$656.89K | -$1.55M | -$11.06M | -$6.81M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hepion Pharmaceuticals, Inc. · CIK 1583771 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 12, 2026 · 71 d after period end
